33
/it/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
November 1, 2025
3512562
319423
2
Create a timeline
Public Timelines
For educational institutions For teachers For students Cabinet
For educational institutions For teachers For students Open cabinet
FAQ Ricevere il Premium
Create a timeline
Public timelines
FAQ
About & FeedbackAccordoPrivatezzaFAQ
Support 24/7  
CabinetGet premium
Donate

1 gen 2013 anni - Ado-Trastuzumab Emtansine (T-DM1)

Descrizione:

For the treatment of patients with HER2-positive breast cancer previously treated with trastuzumab and/or a taxane drug, the FDA recommends ado-trastuzumab emtansine (T-DM1).

Aggiunto al nastro di tempo:

Cancer

ByTrinity Ozias
14 nov 2019
0
0
302

Data:

1 gen 2013 anni
Adesso
~ 12 years ago
About & FeedbackAccordoPrivatezzaFAQ
Support 24/7  
CabinetGet premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL